Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep intervention for children with ADHD
NCT00867451Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in attention deficit hyperactivity disorder (ADHD), sponsored by Cincinnati Children's Hospital Medical Center. Started Jan 2010; status: completed.
02
Drugs
melatonin
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00867451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00867451.